Clinical trial
Delineation of Novel Monogenic Disorders in the United Arab Emirates
NCT03589079 is registered in ClinicalTrials.gov with Imperial College London Diabetes Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Delineation of Novel Monogenic Disorders in the United Arab Emirates
- Lead sponsor
- Imperial College London Diabetes Centre
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2018
- Completion date
- January 31, 2021
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
de novo mutation, genetic disorder, hereditary disorder, inherited disease, mendelian disorders, novel mutation, single-gene defects